GI
CLB icon

GAMMA Investing’s Core Laboratories CLB Stock Holding History

GAMMA Investing’s Portfolio CLB Stock Details CLB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$56.2K Sell
4,820
-1,521
-24% -$21.7K ﹤0.01% 2225
2026
Q1 		$106K Buy
6,341
+1,184
+23% +$21.2K 0.01% 1621
2025
Q4 		$82.7K Buy
5,157
+2,181
+73% +$32.5K ﹤0.01% 1709
2025
Q3 		$36.8K Buy
2,976
+777
+35% +$9.11K ﹤0.01% 2185
2025
Q2 		$25.3K Sell
2,199
-2,382
-52% -$28.3K ﹤0.01% 2340
2025
Q1 		$68.7K Sell
4,581
-1,821
-28% -$30.5K 0.01% 1554
2024
Q4 		$111K Buy
6,402
+517
+9% +$9.98K 0.01% 1038
2024
Q3 		$109K Buy
5,885
+1,460
+33% +$29.3K 0.01% 937
2024
Q2 		$89.8K Buy
4,425
+855
+24% +$15.1K 0.01% 842
2024
Q1 		$61K Buy
3,570
+857
+32% +$13.5K 0.01% 905
2023
Q4 		$42.8K Buy
+2,713
New +$54.7K 0.01% 993

Other funds holding CLB

CAMG
CWA Asset Management Group Naples, Florida $3.28B AUM 34.07% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return
YCM
Yousif Capital Management Bloomfield Hills, Michigan $8.94B AUM 42.6% 1-Year Est. Return
COPPSERS
Commonwealth of Pennsylvania Public School Employees Retirement System Harrisburg, Pennsylvania $20.6B AUM 37.37% 1-Year Est. Return
SWM
Spire Wealth Management Mclean, Virginia $3.31B AUM 38.78% 1-Year Est. Return
CWP
Curated Wealth Partners El Segundo, California $774M AUM 5.71% 1-Year Est. Return
VCM
Versant Capital Management Phoenix, Arizona $1.12B AUM 34.21% 1-Year Est. Return
CMA
Cedar Mountain Advisors Lake Oswego, Oregon $581M AUM 18.16% 1-Year Est. Return
S
Sachetta Lynnfield, Massachusetts $206M AUM 26.19% 1-Year Est. Return
JWA
JFS Wealth Advisors Hermitage, Pennsylvania $2.01B AUM 21.74% 1-Year Est. Return

GAMMA Investing's CLB Position: Q2 2026 in Review

GAMMA Investing reduced its Core Laboratories (CLB) stake by 24% in Q2 2026, selling an estimated $21.7K and leaving 4,820 shares worth $56.2K. The position accounts for ﹤0.01% of the portfolio, ranked #2225.

GAMMA Investing first reported a position in CLB in Q4 2023 and has held it in 11 quarters since. The position peaked at $111K in Q4 2024. 11 funds tracked by Wall St. Rank hold CLB as of Q2 2026.

  • GAMMA Investing held 4,820 shares of Core Laboratories worth $56.2K as of Q2 2026.
  • GAMMA Investing sold 1,521 Core Laboratories shares in Q2 2026, an estimated $21.7K.
  • Core Laboratories made up ﹤0.01% of GAMMA Investing's portfolio in Q2 2026, its #2225 holding.
  • GAMMA Investing first reported a position in Core Laboratories in Q4 2023 and has held it in 11 quarters since.
  • GAMMA Investing's Core Laboratories position peaked at $111K in Q4 2024.
  • 11 funds tracked by Wall St. Rank held Core Laboratories as of Q2 2026.

Based on GAMMA Investing's 13F filing for Q2 2026, filed 7 Jul 2026.